These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3508559)

  • 1. Hypolipidemic activity of o-(N-phthalimido)acetophenone in Sprague Dawley rats.
    Hall IH; Reynolds DJ; Wong OT; Oswald CB; Murthy AR
    Pharm Res; 1987 Dec; 4(6):472-9. PubMed ID: 3508559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hypolipidemic activity of 1-N-3-methylphthalimido-butan-3-semicarbazone in rodents.
    Wong OT; Hall IH; Chapman JM
    Pharm Res; 1989 Mar; 6(3):230-4. PubMed ID: 2726679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and hypolipidemic activity of 3-imino-1-oxoisoindolines in rodents.
    Murthy AR; Wong OT; Reynolds DJ; Hall IH
    Pharm Res; 1987 Feb; 4(1):21-7. PubMed ID: 3508524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypolipidemic activity of phthalimide derivatives. 2. N-phenylphthalimide and derivatives.
    Chapman JM; Voorstad PJ; Cocolas GH; Hall IH
    J Med Chem; 1983 Feb; 26(2):237-43. PubMed ID: 6131131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of 2,3-dihydrophthalazine-1,4-dione on Sprague Dawley rats lipid metabolism and serum lipoproteins.
    Hall IH; Wong OT; Reynolds DJ; Oswald CB
    Biomed Biochim Acta; 1988; 47(4-5):423-33. PubMed ID: 3240293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The disposition of the hypolipidemic agent, o-(N-phthalimido)acetophenone, in Sprague-Dawley rats.
    Hall IH; Reynolds DJ; Wyrick SD; Maguire JH; Shrewsbury RP
    Drug Metab Dispos; 1988; 16(2):196-200. PubMed ID: 2898332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypolipidemic activity of N,N-dimethyl-n-octadecylamine borane in rodents.
    Hall IH; Griffin TS; Docks EL; Brotherton RJ; Futch G
    J Pharm Sci; 1986 Jul; 75(7):706-10. PubMed ID: 3761173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hypolipidemic activity of N(4-methyl-phenyl)diphenimide in rodents.
    Hall IH; Wong OT; Murthy AR; Day PA; Calvin J
    Pharmacol Res Commun; 1987 Dec; 19(12):839-58. PubMed ID: 3448609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypolipidemic activity of the surfactants aminimides, and their effects on lipid metabolism of rodents.
    Hall IH; Kabara JJ; Matthews TG
    Lipids; 1985 Oct; 20(10):685-92. PubMed ID: 2865666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of phthalimide and saccharin derivatives on low-density lipoprotein (LDL) and high-density lipoprotein (HDL) receptor activity and related enzyme activities.
    Hall IH; Wong OT; Wyrick SD
    Pharm Res; 1988 Jul; 5(7):413-20. PubMed ID: 2854633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of 3,5-isoxazolidinediones as hypolipidemic agents in rodents.
    Woodard T; Debnath ML; Simlot R; Izydore RA; Daniels DL; Wong OT; ElSourady H; Hall IH
    Pharm Res; 1995 Jan; 12(1):24-38. PubMed ID: 7724485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of isoxazolidine or triazolidine on rat serum lipids in vivo and LDL and HDL binding and degradation in human and rodent cultured cells in vitro.
    Hall IH; Wong OT; Simlot R; Izydore RA
    Res Commun Chem Pathol Pharmacol; 1992 Sep; 77(3):327-46. PubMed ID: 1333628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of 2-(2,4-dimethylphenyl)indan-1,3-dione on serum lipoprotein and lipid metabolism of rodents.
    Hall IH; Murthy AR; Day PA; Clavin J
    Lipids; 1988 Aug; 23(8):755-60. PubMed ID: 3185107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypolipidemic activity of a series of N-pyridinyl and N-quinolinyl substituted derivatives of phthalimide and succinimides in rodents.
    Hall IH; Wong OT; Futch G; Scovill JP
    Biomed Biochim Acta; 1990; 49(1):103-13. PubMed ID: 2360899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihyperlipidemic activity of phthalimide analogues in rodents.
    Hall IH; Voorstad PJ; Chapman JM; Cocolas GH
    J Pharm Sci; 1983 Aug; 72(8):845-51. PubMed ID: 6620134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypolipidemic activity of 3- and 4-phenyl-piperidine-2,6-diones and selected N-substituted derivatives.
    Murthy AR; Maguire JH; Alphin RS; Day PA; Hall IH
    Lipids; 1986 Oct; 21(10):617-22. PubMed ID: 3796228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypolipidemic effects of 6-amino-2-mercapto-5-methylpyrimidine-4-carboxylic acid in rats and tissue culture cells.
    Hall IH; Wong OT; Reynolds DJ; Simlot R; Chang JJ
    J Pharm Sci; 1993 Jan; 82(1):60-8. PubMed ID: 8429494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure activity relationships of imido N-alkyl semicarbazones, thiosemicarbazones and acethydrazones as hypolipidemic agents in rodents.
    Chapman JM; DeLucy P; Wong OT; Hall IH
    Lipids; 1990 Jul; 25(7):391-7. PubMed ID: 2395418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and hypolipidemic activity of amine-carboxyboranes, and their amides and esters in rodents.
    Sood A; Sood CK; Spielvogel BF; Hall IH; Wong OT; Mittakanti M; Morse K
    Arch Pharm (Weinheim); 1991 Jul; 324(7):423-32. PubMed ID: 1763952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypolipidemic activity of 6-alkoxycarbonyl-3-aryl-1,3,5- triazabicyclo[3.1.0]hexane-2,4-diones and 2-alkoxycarbonyl-5-aryl-1,3,5-triazine-4,6(1H,5H)-diones in rodents.
    Izydore RA; Wong OT; Hall IH
    Lipids; 1993 Mar; 28(3):223-9. PubMed ID: 8464353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.